Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma

Table 2

Association of BMPs/BMP receptors expression with prognosis in LUAD patients revealed by Kaplan-Meier Plotter.

Name	Cut-off value (counts)	Range (counts)	value	HR	No. patients
BMP2	337	5–7330	0.0002	0.64 (0.51-0.81)	719
BMP3	49	1–1053	0.1001	0.82 (0.65-1.04)	719
BMP4	26	2 –5308	0.0239	0.76 (0.60-0.96)	719
BMP5	86	0–4234	6.90E-09	0.50 (0.39-0.63)	719
BMP6	185	4–8180	0.9815	1.00 (0.79-1.26)	719
BMP7	156	1–3030	0.2600	1.17 (0.89-1.54)	719
BMPR1A	370	6–1789	1.60E-08	0.50 (0.39-0.64)	719
BMPR1B	42	-1–5621	0.2820	0.85 (0.62-1.15)	672
BMPR2	752	-1–9643	0.0444	0.75 (0.56-0.99)	672
ACVR1	1283	138–4666	1.20E-07	0.54 (0.42-0.68)	719
ACVR1B	307	5–2312	0.0015	1.45 (1.15-1.83)	719
ACVR1C	50	-1–2919	0.4622	1.11 (0.85-1.44)	672
ACVR2A	168	-1–1710	0.0007	0.64 (0.49-0.83)	672
ACVR2B	8	-1–382	0.7751	1.04 (0.80-1.35)	672
ACVRL1	133	-1–3761	0.0158	0.64 (0.44-0.92)	672
TGFBR1	1212	-1–13618	0.1066	0.80 (0.61-1.05)	672
TGFBR2	41	1–658	0.0377	1.28 (1.01-1.63)	719
TGFBR3	268	-1–12138	0.0003	0.61 (0.47-0.80)	672